
Lorlatinib: an additional option for ALK-positive non-small cell lung cancer?
Author(s) -
Alice Mogenet,
Pascale Tomasini,
L. Greillier,
Fabrice Barlési
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.05.10
Subject(s) - medicine , lung cancer , cancer research , oncology , bioinformatics , biology